Results 241 to 250 of about 40,797 (259)
Some of the next articles are maybe not open access.
Thromboprophylaxis during chemotherapy: NO
Thrombosis Research, 2010There is a wide range in rates of thrombosis in patients on chemotherapy reported in the literature. This is likely as a result of study design and case selection. The interest in primary prevention of venous thromboembolism in patients on chemotherapy has been rekindled by the association between antiangiogenic agents and thrombosis.
openaire +2 more sources
Thromboprophylaxis in medical patients
Hospital Medicine, 2000Recent clinical studies have confirmed that acutely ill medical patients are at substantial risk of venous thromboembolism, which can be reduced by thromboprophylaxis with low molecular weight heparin. These studies have resulted in approval of a low molecular weight heparin (enoxaparin) for the prophylaxis of venous thromboembolism in medical ...
openaire +2 more sources
British journal of hospital medicine, 1996
Thromboembolism in pregnancy is a major cause of maternal mortality. Pregnancy, particularly caesarean section, increases the risk of thrombosis. This article discusses the risk factors, the drugs used and the indications for prophylaxis of thromboembolism in pregnancy.
openaire +1 more source
Thromboembolism in pregnancy is a major cause of maternal mortality. Pregnancy, particularly caesarean section, increases the risk of thrombosis. This article discusses the risk factors, the drugs used and the indications for prophylaxis of thromboembolism in pregnancy.
openaire +1 more source
Thromboprophylaxis in cancer surgery
2011The presence of cancer, overt or occult, is thrombogenic to the individual. This has been recognised from the time of Armand Trousseau who, in 1865 [1], stated: “I have long been struck with the frequency with which cancerous patients are affected with painful oedema of the superior or inferior extremities, whether or not either was the seat of the ...
David Gozzard, David Perry
openaire +1 more source